Gene · 3093
Papers3,161
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 3,161
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Cerebellar Involvement in Autism Spectrum Disorders: From the Social Brain to Mouse Models. | Int J Mol Sci | 2022 | 35409253 | PubTator, text mining | PubMed |
| The Next Frontier: Translational Development of Ubiquitination, SUMOylation, and NEDDylation in Cancer. | Int J Mol Sci | 2022 | 35408841 | PubTator, text mining | PubMed |
| Transcriptional CDK Inhibitors as Potential Treatment Option for Testicular Germ Cell Tumors. | Cancers (Basel) | 2022 | 35406461 | PubTator, text mining | PubMed |
| A Review of the Current Impact of Inhibitors of Apoptosis Proteins and Their Repression in Cancer. | Cancers (Basel) | 2022 | 35406442 | PubTator, text mining | PubMed |
| Site-Specific Detection and Characterization of Ubiquitin Carbamylation. | Biochemistry | 2022 | 35380792 | PubTator, text mining | PubMed |
| Hyperactivating p53 in Human Papillomavirus-Driven Cancers: A Potential Therapeutic Intervention. | Mol Diagn Ther | 2022 | 35380358 | PubTator, text mining | PubMed |
| Transcriptomics Reveals the Mevalonate and Cholesterol Pathways Blocking as Part of the Bacterial Cyclodipeptides Cytotoxic Effects in HeLa Cells of Human Cervix Adenocarcinoma. | Front Oncol | 2022 | 35359411 | PubTator, text mining | PubMed |
| Ogt Demonstrated Conspicuous Clinical Significance in Cancers, from Pan-Cancer to Small-Cell Lung Cancer. | J Oncol | 2022 | 35356257 | PubTator, text mining | PubMed |
Identification and Validation of a Ferroptosis-Related Long Non-Coding RNA (FRlncRNA) Signature to Predict Survival Outcomes and the Immune Microenvironment in Patients With Clear Cell Renal Cell Carcinoma. | Front Genet | 2022 | 35350243 | PubTator, text mining | PubMed |
| Stimulant intolerance in children with Angelman syndrome with hyperactivity: a case series. | Psychiatr Genet | 2022 | 35348128 | PubTator, text mining | PubMed |
| Choosing Kinase Inhibitors for Androgen Deprivation Therapy-Resistant Prostate Cancer. | Pharmaceutics | 2022 | 35335873 | PubTator, text mining | PubMed |
| Design, Synthesis and Adsorption Evaluation of Bio-Based Lignin/Chitosan Beads for Congo Red Removal. | Materials (Basel) | 2022 | 35329763 | PubTator, text mining | PubMed |
| The Role of NEDD4 E3 Ubiquitin-Protein Ligases in Parkinson's Disease. | Genes (Basel) | 2022 | 35328067 | PubTator, text mining | PubMed |
| Association of Genetically Predicted BCAA Levels with Muscle Fiber Size in Athletes Consuming Protein. | Genes (Basel) | 2022 | 35327951 | PubTator, text mining | PubMed |
| Acetylation, Phosphorylation, Ubiquitination (Oh My!): Following Post-Translational Modifications on the Ubiquitin Road. | Biomolecules | 2022 | 35327659 | PubTator, text mining | PubMed |
| Network Theoretical Approach to Explore Factors Affecting Signal Propagation and Stability in Dementia's Protein-Protein Interaction Network. | Biomolecules | 2022 | 35327643 | PubTator, text mining | PubMed |
| Renal Cell Carcinoma in End-Stage Renal Disease: A Review and Update. | Biomedicines | 2022 | 35327459 | PubTator, text mining | PubMed |
| Polymyxin Induces Significant Transcriptomic Perturbations of Cellular Signalling Networks in Human Lung Epithelial Cells. | Antibiotics (Basel) | 2022 | 35326770 | PubTator, text mining | PubMed |
| Multi-omics landscape and clinical significance of a SMAD4-driven immune signature: Implications for risk stratification and frontline therapies in pancreatic cancer. | Comput Struct Biotechnol J | 2022 | 35317237 | PubTator, text mining | PubMed |
| NEDD4L inhibits glycolysis and proliferation of cancer cells in oral squamous cell carcinoma by inducing ENO1 ubiquitination and degradation. | Cancer Biol Ther | 2022 | 35316145 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3093/papers?page=39